GSDME, as a tumor suppressor, can improve the antitumor immunity by activation of pyroptosis, while inflammasome activation induced by pyroptosis further enhances the therapeutic efficacy of some immune checkpoint blockers [16, 17]. This evidence concerns the gene GSDME and neoplasm.